Navigation Links
Alere Inc. Announces Fourth Quarter 2010 Results
Date:2/17/2011

>

(29,931)144,214

(r) 114,28315,627110,398

(r) 126,025 Income (loss) from continuing operations before equity earnings of unconsolidated entities, net of tax

(1,037,855)1,280,140242,28524,621210,799235,420Equity earnings of unconsolidated entities, net of tax

10,5663,750

(b) (c) 14,3167,6266,226

(b) (c) 13,852Income (loss) from continuing operations

(1,027,289)1,283,890256,60132,247217,025249,272Income (loss) from discontinued operations, net of tax

11,397191

(k) 11,5881,9341,226

(k) (b) 3,160Net income (loss)

(1,015,892)1,284,081268,18934,181218,251252,432Less: Net income attributable to non-controlling interests, net of tax

1,4183,714

(l) 5,132465-465Net income (loss) attributable to Alere Inc. and Subsidiaries

$ (1,017,310)$
,280,367$
263,057$
33,716$
218,251$
251,967Preferred stock dividends

$
(24,235)$
(24,235)$
(22,972)$
(22,972)Net income (loss) available to common stockholders

$ (1,041,545)$
238,822$
,744$
228,995Basic net income (loss) per common share attributable to Alere Inc. and Subsidiaries:Basic income (loss) per common share from continuing operations

$
(12.47)$
2.69$
.11$
2.80Basic income (loss) per common share from discontinued operations

$
.14$
.14$
.02$
.04Basic net income (loss) per common share$
(12.33)$
2.83$
.13$
2.84Diluted net income (loss) per common share attributable to Alere Inc. and Subsidiaries:Diluted income (loss) per common share from continuing operations

$
(12.47)

(s) $
2.51

(u) $
.11

(t) $
2.60

(v) Diluted income (loss) per common share from discontinued operations

$
.14

(s) $
.11

(u) $
.02

(t) $
.03

(v) Diluted net income (loss) per common share$
(12.33)

(s) $'/>"/>

SOURCE Alere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Inverness Medical Innovations Changes Name to Alere
2. Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
3. Alere and AirStrip Technologies - a Powerful Collaboration Brings Innovative Remote Patient Monitoring to Obstetrical Care
4. Alere Inc. Announces Offering of $350 Million of Senior Subordinated Notes
5. Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million
6. Alere to Attend the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010
7. Alere to Attend the Lazard Capital Markets 7th Annual Healthcare Conference on November 17, 2010
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...   Cepheid (Nasdaq: CPHD ) today announced ... second quarter ended June 30, 2015 on Thursday, July ... The Company will host a management presentation at ... to discuss the results.  To access the live webcast, ... least 15 minutes before the scheduled start time to ...
(Date:7/6/2015)... , July 6, 2015 Akcea Therapeutics, ... ISIS ), announced today that the U.S. ... Designation to volanesorsen (ISIS-APOCIII Rx ) for the ... FCS is a rare genetic disease characterized by ... In a Phase 2 study published in the ...
(Date:7/6/2015)... SHENZHEN, China , July 6, 2015 China ... CNIT), a leading provider of integrated cloud-based platform, exchange, ... , today announced that the Company launched its mobile ... age of accessible healthcare services on mobile devices. The ... District Health and Family Planning Bureau and Shenzhen News ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... DIEGO, Dec. 9 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... Brian M. Culley, will present to investors as part of ... 15, 2009 at 9:30 a.m. Eastern time. , Interested parties ... www.informedinvestors.com , a link to which is available on ...
... , WALTHAM, Mass., ... research and advisory firms focusing on pharmaceutical and healthcare issues, ... claims data, TNF-alpha inhibitors are being used more often to ... as many newly diagnosed second-line patients received a TNF-alpha inhibitor ...
Cached Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3
(Date:7/6/2015)... Georgia (PRWEB) , ... July 06, 2015 , ... ... has received nearly $400,000 in grant funds to support a three-year effort to ... , The work will be conducted in partnership with the Morehouse School of ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took ... Newport News, VA. The procedure was an L5-S1 posterior lumbar interbody fusion on ...
(Date:7/5/2015)... (PRWEB) , ... July 06, 2015 , ... ... ancillary benefits market, is excited to announce the next generation of PrimeStar Individual ... Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and usual, ...
(Date:7/5/2015)... ... ... Women’s Excellence in Wellness, powered by Movestrong is offering a student ... 2 months of unlimited classes for just $65. Student ID is needed at registration. ... Road in Lake Orion. , Women’s Excellence is the most comprehensive ...
(Date:7/4/2015)... ... , ... Chronic Neck Pain. Neck pain is no small problem. ... neck. Another 19% suffer from head, migraine, or facial pain, in some cases related ... American workers must deal with neck pain. Strategies for mitigating neck pain ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3
... A new study finds that people with prediabetes are no ... small fiber polyneuropathy than healthy people, a finding that contradicts ... said the results from their five-year study of 550 people ... in patients with painful small fiber polyneuropathy. Prediabetes, also ...
... , FRIDAY, Feb. 24 (HealthDay News) --,New ... predict age-related macular degeneration, one of the leading causes ... (AMD) were especially likely to have an overexpression of ... University of California Santa Barbara (UCSB), the University of ...
... in tumors., Invasion and metastasis were blocked by inhibition ... late-stage clinical trials. PHILADELPHIA Dual inhibition ... tumor invasion and metastasis in a laboratory model of ... Cancer Discovery , the newest journal of the ...
... Voluminous research literature attests to the multiple negative ... health and development of children. In contrast, there is ... fathers according to a follow up study by NYU ... edition of Maternal and Child Health Journal. ...
... features such as behavior, coat color and susceptibility to ... possible genetic cause for differential gene expression and biological ... pieces of mobile DNA that exist in the genome ... mice, according to a new study led by researchers ...
... , THURSDAY, Feb. 23 (HealthDay News) -- Noninvasive, ... its ability to detect colorectal cancer and precancerous polyps ... Virtual colonoscopy, also called CT colonography, uses virtual-reality ... and rectum. While preferred by many patients, its effectiveness ...
Cached Medicine News:Health News:Researchers Spot Genes Behind Macular Degeneration 2Health News:Combined inhibition of VEGF and c-MET can decrease metastasis 2Health News:Characteristics of fathers with depressive symptoms 2Health News:Characteristics of fathers with depressive symptoms 3Health News:Mobile DNA elements can disrupt gene expression and cause biological variation, study shows 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 3
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
Medicine Products: